Fouremm,

Are you referring to patient safety follow up visits to close out the trial, or comprehensive analysis of the full data set beyond primary MACE endpoint? Check out this summary of Amarin's REDUCE-IT order of events, paying attention to last patient study visits and top-line guidance. I'm pretty sure all patients need to have last study visit in order for the database to be locked for data analysis, including top-line.

BearDownAZ